Today, the granulocyte colony-stimulating factor (G-CSF) is widely used as a prophylactic treatment to counteract neutropenia and to prevent infections, for instance, in patients undergoing systemic chemotherapy (18, 19). This evidence concerns the gene CSF3 and infection.